Maximize the use of your software. Buy only what you need

Dec 11, 2017 | Blogs, Software, Technology | 0 comments

The latest releases of Analyst Software 1.7 and SCIEX OS Software 1.4 introduce a new licensing model called concurrent licensing. If you want flexibility and cost savings when purchasing and using your processing software, concurrent licensing is for you.

How does it work? Concurrent licenses float through the network and are passed from user to user, machine to machine. In other words, access to the software can be granted based on the number of licenses expected to be used at the same time.

So what, you ask? Good question.

The concurrent licensing model can be significantly less costly for your organization than the single device model. This means your tier 2 and tier 3 lab analyst with lower software utilization rates can now share access easily especially when access is not needed at the same time. Get a Better Understanding of Concurrent Software Licenses >

By choosing the concurrent licensing model, your organization can be more:

  • Thrifty:  Avoid overpaying for software licenses and effectively manage your software spend. Track your team’s true software consumption and easily cancel unused licenses; while share underutilized licenses within the team
  • Strategic: Simplifies administration as you can manage licenses for multiple users from one central platform and consolidate license renewal dates across your organization
  • Productive: Allows on-demand license access for local and remote teams within same time zone so users can access the software from any device within the network
  • Diligent: Ensure license compliance and eliminate the potential of costly and unexpected audit penalties

Enjoy the benefits of SCIEX software solutions and take full advantage of the flexible licensing model for your processing software.

For more questions on licensing, get in touch with our software sales specialists >

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network